Lab marker
Testosterone (total)
Total testosterone · TT
The principal androgen, modestly informative for libido, energy, body composition, and bone health in men.
What it measures
Total serum testosterone, the sum of free, albumin-bound, and SHBG-bound testosterone. Reported in nmol/L (SI) or ng/dL (US units). Declines naturally with age in men; in women, contributes to libido and lean mass.
Reference context
2 guideline sources
Reference ranges vary by assay and lab. Two confirmed low morning values plus consistent symptoms are needed before considering replacement. Population averages decline gradually with age, but treatment decisions should rest on symptoms and confirmed lab evidence, not age alone.
Population context: consult guideline targets below
Mechanism
Why moving this marker matters
Testosterone supports skeletal muscle protein synthesis, bone mineralisation, erythropoiesis, libido, and mood. Symptomatic male hypogonadism, confirmed low testosterone plus consistent symptoms, is associated with reduced quality of life and worse cardiometabolic profile.
Guideline targets
What major guidelines recommend
Endocrine Society 2018 (men, lower limit of normal)
~9.2 nmol/L (264 ng/dL) on a morning fasting sample, harmonised assay (the AUA uses 300 ng/dL, ~10.4 nmol/L)
Common reference (men, mid-range)
~13–25 nmol/L (~380–720 ng/dL)
How to measure
The test, where to get it, when to repeat
Method
Fasting morning blood draw (testosterone follows a diurnal rhythm, peaking 7–10am). LC-MS/MS preferred over immunoassay at lower concentrations.
Where
GP request or private lab.
Typical cost
€20–50 private.
Fasting
Required
When to test
Endocrine Society 2018 (men)
maleMeasure in men with consistent symptoms (low libido, fatigue, depressed mood, reduced muscle mass). Repeat for confirmation before treating.
ISSWSH 2021 (women)
femaleTestosterone levels are not used to diagnose low sexual desire in women; a baseline level may be measured before and during testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. Routine measurement is not recommended.
Where to test
Independent labs offering this test
Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.
Randox Health
UK · EU · INTLClinic-based premium panels — wider biomarker breadth than home-test brands.
Visit Randox Health
Synlab
DE · EU · INTLEurope-wide medical lab network — referrals via partner GPs and direct-to-consumer programmes where offered.
Visit Synlab
Cerascreen
DE · EUEstablished German home-test catalogue — ISO-certified labs, German-language reports.
Visit Cerascreen
Medichecks
UKUKAS-accredited home blood-test panels with GP-equivalent biomarker coverage.
Visit Medichecks
Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.
Context
Reading the numbers
Reference ranges vary by assay and lab. Two confirmed low morning values plus consistent symptoms are needed before considering replacement. Population averages decline gradually with age, but treatment decisions should rest on symptoms and confirmed lab evidence, not age alone.
Caveats
Acute illness, recent strenuous exercise, opioid use, and sleep deprivation all transiently suppress testosterone. SHBG variability strongly affects total testosterone; consider free or bioavailable testosterone when SHBG is at extremes.
Practices
What's been shown to influence this marker
Resistance exercise raises testosterone briefly after a session; effects on resting levels are small and inconsistent, and smaller in older or already-trained men (Kraemer 2005 review).
Weight loss in adults with obesity produces clinically meaningful testosterone increases (Mediterranean + caloric reduction). Effect is from adipose-driven aromatisation reduction, not direct dietary effect.
HabitResistance training
2 sessions/week, the amount WHO advises from age 65; trials in adults 60+ show gains in muscle mass and strength.
Why
Sarcopenia (age-related muscle loss) starts in the third decade and accelerates from 50. A network meta-analysis of 151 randomised trials in adults 60+ found resistance training improved lean body mass, muscle size, lower-limb strength and timed walking and mobility tests. WHO advises muscle-strengthening on two or more days a week for adults 65 and over.
Slot in your day
How to do it
How
Six compound movements (squat, hinge, push, pull, carry, rotate), 2–3 sets each, 2× per week. Bodyweight is fine to start; progress to weighted as form solidifies.
Ideal for
Adults over 60, where the trials are; younger adults can reasonably start earlier.
Sticking with it
Two fixed weekday slots beat 'three sessions whenever'. The schedule is the programme.
Markers this may influence
Evidence
Radaelli 2025 Sports Med systematic review and network meta-analysis (151 RCTs, n=6,306): resistance training in adults 60+ improved lean body mass, muscle size, lower-limb strength and timed function tests. In Villareal 2017 N Engl J Med (RCT, n=160, dieting obese older adults), resistance training limited lean-mass loss to 2%, versus 5% with aerobic training. WHO advises muscle strengthening on two or more days a week from age 65.
GRADE certainty: Moderate — rated by Healicus using the GRADE method
- Radaelli R et al., Effects of Resistance Training Volume on Physical Function, Lean Body Mass and Lower-Body Muscle Hypertrophy and Strength in Older Adults: A Systematic Review and Network Meta-analysis of 151 Randomised Trials, Sports Med 2025
- Villareal DT et al., Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults, N Engl J Med 2017
- Mertz KH et al., The effect of daily protein supplementation, with or without resistance training for 1 year, on muscle size, strength, and function in healthy older adults: A randomized controlled trial, Am J Clin Nutr 2021
- Liao CD et al., Effects of protein supplementation combined with resistance exercise on body composition and physical function in older adults: a systematic review and meta-analysis, Am J Clin Nutr 2017
- Valenzuela PL et al., Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials, Lancet Healthy Longev 2023
- WHO guideline (2020): WHO Guidelines on Physical Activity and Sedentary Behaviour (2020)
HabitZone 2 cardio
Conversational-pace cardio, 150+ minutes per week, in line with WHO's moderate-intensity guideline.
Why
Zone 2 is the intensity at which you can still hold a conversation but a song would be a stretch, roughly 60–70% of max heart rate. This exact intensity has not been tested; WHO strongly recommends 150–300 minutes a week of moderate-intensity aerobic activity for adults, and cohort studies link that kind of activity to lower all-cause mortality. Sustained Zone 2 work is proposed to increase mitochondrial density and improve fat oxidation.
Slot in your day
How to do it
How
Brisk walk, easy bike, slow jog. 30 minutes × 5 days, or 45–60 min × 3 days. The 'talk test' is the simplest gauge.
Ideal for
Anyone over 30; especially valuable as the foundation before adding higher-intensity work.
Sticking with it
Schedule it like a meeting. The session you 'fit in if there's time' is the session that doesn't happen.
Markers this may influence
Evidence
WHO's 2020 physical activity guidelines strongly recommend 150-300 minutes a week of moderate-intensity aerobic activity for adults, on moderate-certainty evidence of lower all-cause and cardiovascular mortality. Kelly 2014 Int J Behav Nutr Phys Act meta-analysis of cohort studies: about 11 MET-hours a week of walking or cycling was associated with 11% and 10% lower all-cause mortality. The specific 'zone 2' intensity was not tested.
GRADE certainty: Moderate — reported by WHO 2020 guidelines (moderate certainty for aerobic activity of 150-300 min/week)
HabitMediterranean dietary pattern
Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.
Why
The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.
Slot in your day
How to do it
How
Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.
Sticking with it
Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.
Markers this may influence
Evidence
Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.
GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)
- Estruch et al., NEJM 2018 (PREDIMED)
- Estruch R et al., Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts, N Engl J Med 2018
- Delgado-Lista J et al., Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial, Lancet 2022
- Rees K et al., Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst Rev 2019
- Dinu M et al., Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials, Eur J Clin Nutr 2018
- Sofi F et al., Adherence to Mediterranean diet and health status: meta-analysis, BMJ 2008
- Psaltopoulou T et al., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis, Ann Neurol 2013
- Valls-Pedret C et al., Mediterranean Diet and Age-Related Cognitive Decline: A Randomized Clinical Trial, JAMA Intern Med 2015
- Petersson SD, Philippou E, Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence, Adv Nutr 2016
- NICE guideline (2020): Acute Coronary Syndromes Guideline (NG185) — Secondary Prevention Visual Summary
- USPSTF guideline (2020): Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions
Take to your physician
Worth discussing
- If low, whether your symptoms align and whether further workup (free testosterone, SHBG, LH/FSH, prolactin) is appropriate.
- If considering replacement, the cardiovascular and prostate-related considerations of current evidence.
- Whether lifestyle interventions (sleep, weight loss, resistance training) might address modest symptoms before medical therapy.
Sources
Cited literature
- [1]Bhasin et al., Endocrine Society, Testosterone therapy in men with hypogonadism(2018)
- [2]Parish et al., ISSWSH Clinical Practice Guideline for the use of systemic testosterone for hypoactive sexual desire disorder in women (J Sex Med)(2021)
- [3]Kraemer & Ratamess, Hormonal responses and adaptations to resistance exercise and training (Sports Med)(2005)
- [4]Corona et al., Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (Eur J Endocrinol)(2013)
Last reviewed October 2026
Keep reading